Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Prepaid Assets (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Prepaid Assets for 13 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Prepaid Assets fell 47.14% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.3 million, a 47.14% decrease, with the full-year FY2025 number at $1.3 million, down 47.14% from a year prior.
  • Prepaid Assets was $1.3 million for Q4 2025 at Niagen Bioscience, down from $2.0 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $4.3 million in Q3 2022 to a low of $972000.0 in Q2 2021.
  • A 5-year average of $2.1 million and a median of $2.1 million in 2024 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: skyrocketed 141.71% in 2022, then plummeted 48.74% in 2023.
  • Niagen Bioscience's Prepaid Assets stood at $1.9 million in 2021, then surged by 59.6% to $3.0 million in 2022, then dropped by 17.43% to $2.4 million in 2023, then rose by 1.31% to $2.5 million in 2024, then tumbled by 47.14% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for NAGE's Prepaid Assets are $1.3 million (Q4 2025), $2.0 million (Q3 2025), and $2.1 million (Q2 2025).